1,3,4,5-tetrahydro-7,8-dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylimino)propyl)-2H-3-benzazepin-2-one hydrochloride,
UL-FS 49,
UL-FS-49,
zatebradine,
zatebradine hydrochloride,
Zatebradine hydrochloride,
91940-87-3,
Zatebradine HCl,
UNII-WJB7DYV16A,
Zatebradine (hydrochloride),
UL-FS49,
WJB7DYV16A,
UL-FS 49,
NCGC00092334-01,
DSSTox_CID_25745,
DSSTox_RID_81090,
DSSTox_GSID_45745,
3-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one hydrochloride,
UL-FS-49,
2H-3-Benzazepin-2-one, 3-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride,
7,8-Dimethoxy-3-[3-[-N-[2-(3,4 dimethoxyphenyl)ethyl]-N-methylamino]propyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride,
CAS-91940-87-3,
C26H36N2O5.ClH,
AC1MIIKF,
Zatebradine(hydrochloride),
ULFS 49CL,
CHEMBL543767,
SCHEMBL1588590,
DTXSID6045745,
CTK5H0702,
ZRNKXJHEQKMWCH-UHFFFAOYSA-N,
UL-FS-49;UL-FS-49CL,
BCP11021,
Tox21_111195,
4166AH,
BN0555,
MFCD06798356,
AKOS024456987,
Tox21_111195_1,
BRS0000250,
CS-3619,
KS-00001D61,
NCGC00092334-02,
HY-13422,
LS-182223,
B6974,
FT-0734393,
Zatebradine hydrochloride, >=98% (HPLC), powder,
1-[7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}-ethyl)-amino]-propane hydrochloride,
3-(3-{[2-(3,4-Dimethoxy-phenyl)-ethyl]-methyl-amino}-propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[d]azepin-2-one hydrochloride,
3-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-2H-3-BENZAZ,
3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride,
3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride,
C26-H36-N2-O5.Cl-H,
CID3045335,
3-[3-[[2- ETHYL]METHYLAMINO]PROPYL]-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-2H-3-BENZAZEPIN-2-ONEHYDROCHLORIDE,
85175-67-3,